BioDrugs
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. It has a 2020 impact factor of 5.807. It is published by Adis International (SpringerNature). Less
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherADIS INT LTD
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1994
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has BioDrugs been publishing? 
The BioDrugs has been publishing since 1994 till date.
How frequently is the BioDrugs published?
BioDrugs is published Bi-monthly.
What is the H-index. SNIP score, Citescore and SJR of BioDrugs?
BioDrugs has a H-index score of 76, Citescore of 10.5, SNIP score of 1.74, & SJR of Q1
Who is the publisher of BioDrugs?
The publisher of BioDrugs is ADIS INT LTD.
Where can I find a journal's aims and scope of BioDrugs?
For the BioDrugs's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of BioDrugs on editage?
For the BioDrugs metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of BioDrugs?
The eISSN number is 1179-190X and pISSN number is 1173-8804 for BioDrugs.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Bevacizumab, Infliximab, Synthetic drugs, Adalimumab, Clinical trial, Immunotherapy, Systematic review, Breast cancer, Rituximab, Objective response, Chimeric antigen receptor, Multiple sclerosis, Confidence interval, Biosimilar, Antibody-drug conjugate, Filgrastim, Etanercept, Epoetin alpha, Trastuzumab.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.